Cardiovascular risk factors associated with smaller brain volumes in regions identified as early predictors of cognitive decline

Radiology

Volumn 278, Issue 1, 2016, Pages 198-204

  Srinivasa, Rajiv N ^a   Rossetti, Heidi C ^a   Gupta, Mohit K ^a   Rosenberg, Roger N ^a   Weiner, Myron F ^a   Peshock, Ronald M ^a   McColl, Roderick W ^a   Hynan, Linda S ^a   Lucarelli, Richard T ^a   King, Kevin S ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BRAIN SIZE; CARDIOVASCULAR RISK; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GENETIC RISK; HEART LEFT VENTRICLE HYPERTROPHY; HIPPOCAMPUS; HUMAN; HYPERTENSION; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONTREAL COGNITIVE ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; POSTERIOR CINGULATE; PRECUNEUS; PRIORITY JOURNAL; REGRESSION ANALYSIS; VOLUMETRY; BRAIN; CARDIOVASCULAR DISEASE; COGNITION DISORDERS; COMPLICATION; MIDDLE AGED; PATHOLOGY; PROCEDURES; RISK FACTOR;

ADULT; AGED; BRAIN; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84952907552     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2015142488     Document Type: Article

References (33)

1. Lehmann M, Koedam EL, Barnes J, et al. Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimers disease. Neurobiol Aging 2012;33(3):627.e1-627.e12
2. Pengas G, Hodges JR, Watson P, Nestor PJ. Focal posterior cingulate atrophy in incipient Alzheimers disease. Neurobiol Aging 2010;31(1):25-33
3. Choo IH, Lee DY, Oh JS, et al. Posterior cingulate cortex atrophy and regional cingulum disruption in mild cognitive impairment and Alzheimers disease. Neurobiol Aging 2010;31(5):772-779
4. Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimers disease in later life: longitudinal, population based study. BMJ 2001;322(7300):1447-1451
5. Debette S, Seshadri S, Beiser A, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011;77(5):461-468
6. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 2005;64(2):277-281
7. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42(9):2672-2713
8. Schuff N, Woerner N, Boreta L, et al. MRI of hippocampal volume loss in early Alzheimers disease in relation to ApoE genotype and biomarkers. Brain 2009;132(Pt 4): 1067-1077
9. Gupta M, King KS, Srinivasa R, et al. Association of 3.0-T brain magnetic resonance imaging biomarkers with cognitive function in the Dallas Heart Study. JAMA Neurol 2015;72(2):170-175
10. Victor RG, Haley RW, Willett DL, et al. The Dallas Heart Study: A population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol 2004;93(12):1473-1480
11. Lucarelli RT, Peshock RM, McColl R, et al. MR imaging of hippocampal asymmetry at 3T in a multiethnic, population-based sample: results from the Dallas Heart Study. AJNR Am J Neuroradiol 2013;34(4):752-757
12. Tamashiro-Duran JH, Squarzoni P, de Souza Duran FL, et al. Cardiovascular risk in cognitively preserved elderlies is associated with glucose hypometabolism in the posterior cingulate cortex and precuneus regardless of brain atrophy and apolipoprotein gene variations. Age (Dordr) 2013;35(3):777-792
13. de Toledo Ferraz Alves TC, Scazufca M, Squarzoni P, et al. Subtle gray matter changes in temporo-parietal cortex associated with cardiovascular risk factors. J Alzheimers Dis 2011;27(3):575-589
14. Seshadri S, Wolf PA, Beiser A, et al. Stroke risk profile, brain volume, and cognitive function: The Framingham Offspring Study. Neurology 2004;63(9):1591-1599
15. Cardenas VA, Reed B, Chao LL, et al. Associations among vascular risk factors, carotid atherosclerosis, and cortical volume and thickness in older adults. Stroke 2012; 43(11):2865-2870
16. de la Torre JC. Vascular risk factors: A ticking time bomb to Alzheimers disease. Am J Alzheimers Dis Other Demen 2013;28(6):551-559
17. den Heijer T, van der Lijn F, Ikram A, et al. Vascular risk factors, apolipoprotein E, and hippocampal decline on magnetic resonance imaging over a 10-year follow-up. Alzheimers Dement 2012;8(5):417-425
18. Fotuhi M, Do D, Jack C. Modifiable factors that alter the size of the hippocampus with ageing. Nat Rev Neurol 2012;8(4):189-202
19. Middleton LE, Yaffe K. Promising strategies for the prevention of dementia. Arch Neurol 2009;66(10):1210-1215
20. Morris JK, Vidoni ED, Perea RD, et al. Insulin resistance and gray matter volume in neurodegenerative disease. Neuroscience 2014;270:139-147
21. Alzheimers Association. 2010 Alzheimers disease facts and figures. Alzheimers Dement 2010;6(2):158-194
22. Nordstrm P, Nordstrm A, Eriksson M, Wahlund LO, Gustafson Y. Risk factors in late adolescence for young-onset dementia in men: A nationwide cohort study. JAMA Intern Med 2013;173(17):1612-1618
23. Singh-Manoux A, Gimeno D, Kivimaki M, Brunner E, Marmot MG. Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: The Whitehall II study. Arterioscler Thromb Vasc Biol 2008;28(8):1556-1562
24. Hughes TM, Rosano C, Evans RW, Kuller LH. Brain cholesterol metabolism, oxysterols, and dementia. J Alzheimers Dis 2013;33(4):891-911
25. Prospective Studies Collaboration, Lewington S, Whitlock G, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-Analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007;370(9602):1829-1839
26. van den Kommer TN, Dik MG, Comijs HC, et al. The role of extracerebral cholesterol homeostasis and ApoE e4 in cognitive decline. Neurobiol Aging 2012;33(3):622.e17-622.e28
27. Solomon A, Leoni V, Kivipelto M, et al. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimers disease. Neurosci Lett 2009;462(1):89-93
28. Stiles AR, Kozlitina J, Thompson BM, Mc-Donald JG, King KS, Russell DW. Genetic, anatomic, and clinical determinants of human serum sterol and vitamin D levels. Proc Natl Acad Sci U S A 2014;111(38):E4006-E4014
29. van de Pol LA, van der Flier WM, Korf ES, Fox NC, Barkhof F, Scheltens P. Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment. Neurology 2007;69(15):1491-1497
30. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimers disease in late onset families. Science 1993;261(5123):921-923
31. Rebeck GW, Kindy M, LaDu MJ. Apolipoprotein E and Alzheimers disease: The protective effects of ApoE2 and E3. J Alzheimers Dis 2002;4(3):145-154
32. Hedman AM, van Haren NE, Schnack HG, Kahn RS, Hulshoff Pol HE. Human brain changes across the life span: A review of 56 longitudinal magnetic resonance imaging studies. Hum Brain Mapp 2012;33(8):1987-2002
33. Launer LJ, Ross GW, Petrovitch H, et al. Midlife blood pressure and dementia: The Honolulu-Asia aging study. Neurobiol Aging 2000;21(1):49-55.